Skip to main content

Glycopyrrolate

NDC 0641-6213 · Hikma Pharmaceuticals USA Inc.

Generic nameGlycopyrrolate
Dosage formINJECTION
RouteINTRAMUSCULAR, INTRAVENOUS
Active ingredient(s)GLYCOPYRROLATE
Strength.2 mg/mL
Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
Marketing categoryNDA

Packages

0641-6213-10 — 10 SYRINGE, GLASS in 1 CARTON (0641-6213-10) / 2 mL in 1 SYRINGE, GLASS (0641-6213-01)

Billed under HCPCS

J1596 — Injection, glycopyrrolate, 0.1 mg Medicare Part B payment limit (ASP + 6%): $0.36

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0404-9776 — Glycopyrrolate, 0404-9777 — Glycopyrrolate, 0404-9782 — Glycopyrrolate, 0404-9867 — GLYCOPYRROLATE, 0517-4601 — Glycopyrrolate, 0517-4602 — Glycopyrrolate, 0517-4605 — Glycopyrrolate, 0517-4620 — Glycopyrrolate, 0615-8617 — GLYCOPYRROLATE, 0641-6212 — Glycopyrrolate, 0781-3825 — Glycopyrrolate, 0781-3827 — Glycopyrrolate, 0781-3829 — Glycopyrrolate, 0781-3831 — Glycopyrrolate, 0904-6709 — Glycopyrrolate, 10122-120 — beclomethasone dipropionate/formoterol fumarate/glycopyrrolate, 10122-121 — beclomethasone dipropionate/formoterol fumarate/glycopyrrolate, 10122-460 — beclomethasone dipropionate/formoterol fumarate/glycopyrrolate, 10122-590 — beclomethasone dipropionate/formoterol fumarate/glycopyrrolate, 13107-014 — GLYCOPYRROLATE, +177 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels